The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

Regeneron and Illumina have joined a major investment ... drug discovery and transform patient care." After the initial sequencing, the biospecimens will be stored to support future multi-omics ...

(1) Since Illumina was included in the "Unreliable Entity List", a number of domestic gene sequencing companies have issued replacement and alternative plans; (2) Illumina issued two statements in ...

The NGS technologies are markedly accelerating multiple research areas, making it feasible to conduct experiments that were previously not affordable or even technically possible. Novel fields and ...

It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the structure and function of genomes. A study involving 14% of the people in Greenland ...

But many reported that their computer screen turned black and white. In a few cases, the change appeared when users inadvertently hit a couple of keys, which modified the display settings. But that’s ...